Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ATG-031 by Antengene for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval
ATG-031 is under clinical development by Antengene and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer). According...
ATG-031 by Antengene for Liver Cancer: Likelihood of Approval
ATG-031 is under clinical development by Antengene and currently in Phase I for Liver Cancer. According to GlobalData, Phase I...
ATG-031 by Antengene for Ovarian Cancer: Likelihood of Approval
ATG-031 is under clinical development by Antengene and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I...
ATG-031 by Antengene for Lung Cancer: Likelihood of Approval
ATG-031 is under clinical development by Antengene and currently in Phase I for Lung Cancer. According to GlobalData, Phase I...
ATG-031 by Antengene for Breast Cancer: Likelihood of Approval
ATG-031 is under clinical development by Antengene and currently in Phase I for Breast Cancer. According to GlobalData, Phase I...